39
Views
9
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Gram-Negative Non-Fermenting Bacteria from Food-Producing Animals are Low Risk for Hospital-Acquired Infections

Pages 702-708 | Published online: 18 Jul 2013

References

  • Stokestad ELR, Jukes TH. Further observations on the an-imal protein factor. Proc Soc Biol Exp Med 1949; 73: 523–528.
  • Stokestad ELR, Jukes TH. The multiple nature of the ani-mal protein factor. J Biol Chem 1950; 180: 647–654.
  • Falkow S, Kennedy D. Antibiotics, animals, and people-again! Science 2001; 291:397.
  • Lu HZ, Weng XH, Li H, Yin YK, Pang MY, Tang YVV. En-terococus faecium- related outbreak with evidence of transmis-sion from pigs to humans. J Clin Microbiol 2002; 40: 913–7.
  • Jensen LB, Hammerum AM, Poulsen RL, Westh H. Van-comycin-resistant Enterococcus faecium strains with highly sim-ilar pulsed-field gel electrophoresis patterns containing similar TN 1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob Agents Chemother 1999; 43: 724–5.
  • Molbak K, Baggesen DL, Aarestrup FM et al. An outbreak of multidrug resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999; 341: 1420–1425.
  • Stern NJ, Hiett KL, Alfredsson GA et al. Campylobacter spp. in Icelandic poultry operations and human disease. Epi-demiol Infect 2003; 130: 23–32.
  • Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin resistant Staphylococcus aureus in Eu-rope. Eur J Clin Microbiol Infect Dis 1994; 13: 50–55.
  • Karanfil LV, Murphy M, Josephson A et al. A cluster of van-comycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195–200.
  • Livermore DM, Yuan M. Antibiotic resistance and produc-tion of extended-spectrum 13-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-424.liChow JW, Fine MJ, Shlaes DM et al. Enterobacter bac-teremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585–590.
  • Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994; 170: 377–383.
  • Struelens MJ, E Carlier N, Maes E Serruys, WG Quint. Nosocomial colonization and infection with multiresistant Acine-tobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp In-fect 1993; 25: 15–32.
  • Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother 2003; 52: 140–1.
  • Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sus-tained hospital outbreak of multiresistant Acinetobacter bau-mannii. J Clin Microbiol 2000; 38: 4086–95.
  • Kelly NM, Falkiner FR, Keane CT. Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbio 1983; 17: 159.
  • Harrigan, WF. Laboratory methods in food microbiology, third edition, Academic Press.
  • Grehn M, A von Graevenitz. Search for Acinetobacter cal-coaceticus subsp. anitratus: enrichment of faecal samples. J Clin Microbio 1978; 8: 342–343.
  • Jawad A, Hawkey PM, Heritage J, Snelling AM. Descrip-tion of Leeds Acinetobacter medium, a new selective and differ-ential medium for isolation of clinically important Acinetobacter spp., and comparison with HereIlea agar and Holton's agar. J Clin Microbio 1994; 30: 1588-1591.
  • Spilker T, Coenye T, Vandmme P, LiPuma JJ. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol 2004; 42: 2074–2079.
  • Dolzani L, Tonin E, Lagatolla C, Prandin L, Monti-Bra-gadin C. Identification of Acinetobacter isolates in the A. Cal-coaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic spacer sequences. J Clin Microbiol 1995; 33: 1108–1113.
  • British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. Antimicrob Agents Chemother 1991; 27: 1–50.
  • British Society for Antimicrobial Chemotherapy. Method for Antimicrobial Susceptibility Testing. Version 5, January 2006 http://www.bsac.org.uk/_dbLdocuments/version_5_.pdf.
  • Ellington MJ, Kistler J, Livermore DM, N Woodford. Mul-tiplex PCR for rapid detection of genes encoding acquired met-allo-I3-lactamases. J Antimicrob Chemother 2007; 59: 321–322.
  • Miranda G, Kelly C, Soloranzano F, Leanos B, Coria R, Patterson JE. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J Clin Microbio 1996; 34: 3138–3141.
  • Livermore DM, N Woodford. Carbapenemases: a problem in waiting? Curr Opin Microbiol 2000; 3: 489–495.
  • Corebella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sus-tained hospital outbreak of multiresistant Acinetobacter bau-mannii. J Clin Microbiol 2000; 38: 4086–4095.
  • Solomon S, Horan T, Andrus M et al. National nosoco-mial infections surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003: Am J Infect Control 2003; 31: 481–498.
  • Hocquet D, Bertrand X, Kohler T, Talon D, Plésiat P. Ge-netic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 2003; 47: 1887–1894.
  • Quinn JP, Studemeister AE, DiVincenzo CA, Lerner SA. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev Infect Dis 1988; 10: 892–898.
  • Livermoor DM. Interplay in impermeability and chromo-somal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36: 2046–2048.
  • Poirel L, Nass T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plas-mid- and integron-born gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44: 891–897.
  • Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-13-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306–25.
  • CHU YH, Afzal-shah M, Houang Elizabeth TS et al. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobac-ter spp. Collected in Hong Kong between 1994 and 1998. Antimicrobio Agents Chemother 2001; 45: 710–714.
  • Caroline J, Henwood CJ, Gatward T et al. Antibiotic re-sistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J Antimicrob Chemother 2002, 49: 479–487.
  • Bertrand X, Mulin B, Viel JF, Thouverez M, Talon D. Common PFGE patterns in antibiotic-resistant Enterococcus fae-calls from humans and cheeses. Food Microbiol 2000; 17: 543–551.
  • Perreten V, Teuber M. Antibiotic resistant bacteria in fer-mented dairy products. A new challenge for raw milk cheeses? 1995 International Dairy Federation, SI 9505, Bruxelles.
  • Messi P, Guerrieri E, de Niederhäusern S, Sabia C, Bondi M. Vancomycin-resistant enterococci (VRE) in meat and envi-ronmental samples. Int J Food Microbiol 2006; 107: 218–222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.